Generative Artificial Intelligence (Gen AI) can rapidly and accurately screen patients for clinical trial eligibility, according to a new study from Mass General Brigham researchers. Such technology ...

Health tech company Inato developed an AI-powered patient prescreening tool to make it easier and faster for research sites to assess patient eligibility for clinical trial opportunities. Launched in ...

Drugs are man-made miracles. They enhance our health, cure diseases, and extend our lives. However, drug development is not easy. It is a remarkably long, expensive, and complex process. On average, ...

The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Guy Yehiav In the U.S., ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...

Clinical trial agreements (CTAs) form the foundation of any clinical research initiative, establishing the legal and operational framework essential for a study's success. Crafting, reviewing, and ...

In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions. This has created ...

Walgreens sees a long runway for its two-year-old clinical trials business as it doubles down on its core retail pharmacy operations. Ramita Tandon, chief clinical trials officer, shared insights ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process. As longtime cancer doctors with regulatory experience, ...

DUBLIN--(BUSINESS WIRE)--The "Clinical Trials Market Forecast Report by Phase, Indication, Study Material, Country and Company 2025-2033" report has been added to ResearchAndMarkets.com's offering.